FAP PET/CT for Staging Patients With Breast Cancer

Summary

This study aims to evaluate the clinical utility of \[68Ga\]Ga-FAP-2268 PET/CT for disease staging and assessment in patients with high-risk primary breast cancer. By targeting fibroblast activation protein (FAP), this novel imaging approach may offer improved tumor visualization compared to conventional imaging, which may help improve treatment planning.

Timeline

Start

2026-06-01

Primary completion

2028-01

Completion

2029-01

Drugs

Indications